MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-19-2026
Guardant Health P/S Ratio 2011-2026 | GH
Annual P/S Ratio Guardant Health
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.7 | 7.91 | 4.44 | 5.92 | 27.1 | 43.8 | 33.4 | 13.4 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 43.8 | 4.44 | 18.7 |
P/S Ratio of other stocks in the Diagnostics research industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
1.72 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Bioventus
BVS
|
1.07 | $ 9.25 | -0.11 % | $ 616 M |  USA |
|
Biodesix
BDSX
|
1.29 | $ 14.56 | -0.27 % | $ 1.89 B | USA |
 |
DarioHealth Corp.
DRIO
|
1.47 | $ 8.45 | - | $ 33.7 M |  Israel |
 |
Enzo Biochem
ENZ
|
0.0018 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
6 | - | - | $ 19.8 B | USA |
|
Akumin
AKU
|
0.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Heska Corporation
HSKA
|
3.28 | - | - | $ 1.31 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
5.71 | - | - | $ 562 M |  Britain |
 |
IDEXX Laboratories
IDXX
|
11.9 | $ 566.57 | -1.17 % | $ 45.6 B | USA |
 |
Medpace Holdings
MEDP
|
5.12 | $ 462.67 | -0.84 % | $ 13.3 B | USA |
 |
Illumina
ILMN
|
3.75 | $ 121.35 | -2.45 % | $ 19.3 B | USA |
 |
Trinity Biotech plc
TRIB
|
1.47 | $ 0.62 | 1.06 % | $ 61.9 M |  Irlanda |
 |
DermTech
DMTK
|
2.77 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
5.55 | - | -6.19 % | $ 10.5 M | USA |
 |
Co-Diagnostics
CODX
|
5.13 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
13.5 | - | -61.36 % | $ 2.46 M | USA |
 |
OPKO Health
OPK
|
6.61 | $ 1.14 | -2.44 % | $ 791 M | USA |
 |
Global Cord Blood Corporation
CO
|
0.196 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
3.48 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
1.36 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
2.9 | - | 0.12 % | $ 80.1 M | China |
 |
National Research Corporation
NRC
|
2.29 | $ 16.93 | -2.48 % | $ 379 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
0.469 | - | -20.0 % | $ 1.06 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
2.47 | - | - | $ 10.7 B | USA |
 |
VolitionRx Limited
VNRX
|
44.4 | $ 0.19 | -3.63 % | $ 18.3 M |  Singapore |
 |
Charles River Laboratories International
CRL
|
1.92 | $ 160.77 | -2.64 % | $ 7.97 B | USA |
 |
Organovo Holdings
ONVO
|
21.5 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
1.76 | - | -16.95 % | $ 1.54 M | USA |
 |
Waters Corporation
WAT
|
21.1 | $ 295.27 | -1.76 % | $ 17.6 B | USA |
 |
Biocept
BIOC
|
0.229 | - | -13.05 % | $ 7.29 M | USA |
 |
ENDRA Life Sciences
NDRA
|
1.59 K | $ 4.79 | 6.32 % | $ 2.57 M | USA |
 |
PerkinElmer
PKI
|
5.13 | - | -0.91 % | $ 14.7 B | USA |
 |
Invitae Corporation
NVTA
|
4.18 | - | - | $ 21.2 M | USA |
 |
Exagen
XGN
|
1.05 | $ 2.71 | -2.87 % | $ 58.4 M | USA |
 |
Interpace Biosciences
IDXG
|
0.0879 | $ 1.73 | 2.37 % | $ 7.59 M | USA |
 |
Soleno Therapeutics
SLNO
|
10.9 | $ 31.12 | -2.23 % | $ 1.58 B | USA |
 |
RadNet
RDNT
|
2.76 | $ 57.9 | -2.54 % | $ 4.35 B | USA |
 |
Motus GI Holdings
MOTS
|
3.1 | - | -34.28 % | $ 263 K | Israel |
 |
QIAGEN N.V.
QGEN
|
5.03 | - | - | $ 10.6 B |  Niderland |
 |
Thermo Fisher Scientific
TMO
|
4.4 | $ 482.91 | -1.22 % | $ 182 B | USA |
 |
Chembio Diagnostics
CEMI
|
0.254 | - | 0.22 % | $ 16.8 M | USA |
 |
Senseonics Holdings
SENS
|
9.94 | $ 6.53 | -0.53 % | $ 272 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.71 | $ 265.93 | -0.91 % | $ 22.1 B | USA |
 |
NeoGenomics
NEO
|
2.04 | $ 7.58 | -2.32 % | $ 971 M | USA |
 |
Psychemedics Corporation
PMD
|
0.761 | - | -1.84 % | $ 15.3 M | USA |
 |
Precipio
PRPO
|
0.572 | $ 26.54 | -2.43 % | $ 34.4 M | USA |
 |
CareDx, Inc
CDNA
|
2.61 | $ 17.22 | -1.43 % | $ 918 M | USA |